title: Is B-type natriuretic peptide a risk factor for heart failure in patients treated with bardoxolone methyl?
authors.affiliation: Illawarra Health and Medical Research Institute, University of Wollongong, Faculty of Science, Medicine and Health, School of Medicine, New South Wales, Australia.
authors.forename: Danielle
authors.initials: D
authors.lastname: Camer
authors.affiliation: Illawarra Health and Medical Research Institute, University of Wollongong, Faculty of Science, Medicine and Health, School of Medicine, New South Wales, Australia.
authors.forename: Xu-Feng
authors.initials: XF
authors.lastname: Huang
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis*; D057239:Early Termination of Clinical Trials; D005260:Female; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D008297:Male; D009828:Oleanolic Acid / Q000031:analogs & derivatives*; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy*
chemical_list: D009828:Oleanolic Acid